Professional Practice Minutes September 7 th, 2016
|
|
- Morgan Franklin
- 5 years ago
- Views:
Transcription
1 Professional Practice Minutes September 7 th, Lung Cancer Screening : Fast Facts Number 1 killer of both men and women in the US (The Global Burden of Cancer 2013) More people die from lung cancer annually than breast, colon, and prostate combined (Rita Edwards) Every 5 mins a women learns she has lung cancer World wide, lung cancer has 1.8 million patients and has caused 1.6 million deaths 75% patients with lung cancer have advanced local or metastatic disease, not amenable to cure (Chest 2006) Survival rate is 16% (CA Cancer J Clin. 2011) In 2012, lung cancer deaths accounted for 27% of all cancer-related deaths in the US In 2016, the American Cancer Society predicts that there will be approximately new cases diagnosed and approximately 158,000 lung cancer associated deaths in US In the US, it has been estimated that 8.6 million people met criteria to be screened and could avert 12,000 deaths of lung cancer annually Lung cancer deaths have begun to decline in men and women due to the decrease in smoking A. Risk Factors: i. Smoking 1. The most important factor in preventing lung cancer is to STOP SMOKING a. Please refer to our awesome Tobacco Dependence program! 2. 85% of lung cancers due to smoking (Rita Edwards) 3. Large population at risk due to cigarette smoking and second hand smoke exposure 4. Approximately 60 million current smokers million former smokers 6. Tobacco is responsible for 1 in 5 deaths and the leading cause of preventable death and illnesses 7. Secondhand Smoke a. More than 126 million are exposed to SHS b. 3,400 lung cancer deaths/ year c. 46,000 heart disease deaths/ year d. Declining: 84% in , 46% in e. 74% of population covered by smoke free policies in work places and restaurants/bars ii. Radiation therapy iii. Other environmental toxins (radon, asbestos, metals) iv. Pulmonary fibrosis v. HIV infection vi. Genetic factors vii. Alcohol viii. Dietary factors B. National Lung Screening Trial Information: On August 4 th, 2011 the New England Journal reported on the study that compared chest x-rays to low dose CAT scans for screening for lung cancer i. 8 years and 53,454 subjects randomized to annual x 3 LDCT vs. CXR ii. 20% lung cancer mortality reduction with the use of low dose CAT scan screening iii. 6.7% all cause mortality reduction iv. Screen 320 individuals to save 1 from lung cancer death v. What was considered positive in the study is any nodule above 4mm
2 C. US Preventive Task force Current Recommendation released on December 2013 D. Lung Screening Guidelines - See screening guide in consult room i. Group 1: years of age 2. Currently a smoker or has quit within the past 15 years 3. Smoked greater than one pack of cigarettes a day for 30+ years ii. Group Smoked one pack or more per day for 20+ years 3. Has one additional risk factor for lung cancer, not to include second hand smoke a. Family history of lung cancer i. Mother, father, sibling, child b. Personal history of chronic lung disease i. COPD, Chronic Bronchitis, Emphysema, Pulmonary Fibrosis c. Occupational exposure to lung carcinogens i. Arsenic, Asbestos, Beryllium, Cadmium, Soot, Chromium, Diesel fumes, Nickel, Silica, Coal smoke d. Radon exposure (Residential, mining, firefighter, military-active combat e. Personal history of cancer (excluding known metastatic disease) i. Lung cancer, lymphoma, head and neck, esophageal, bladder, cervix, colon, kidney, pancreas, stomach E. Harms of Lung Cancer Screenings 1. False positives: 96% of positive tests will not be cancer 2. Radiation exposure: a low dose cat scan is only 1/3 radiation of chest x-ray 3. Patient distress 4. Over diagnosis: we do not know how many of the diagnosis made would have led to the patient s death F. Shared Decision Making i. Always document if you suggest screening and the patient refuses ii. Patients and providers make decisions together based on the best scientific evidence available and the patients values and preferences iii. Honors provider s knowledge and patients right to be fully informed of all care options and potential harms and benefits iv. Gives patients support to make the best individualized care decisions 2. Hepatitis C Screening A. Pennsylvania s Hepatitis C Screening Act i. Signed in to law by PA Governor Tom Wolf on July 20, If goes into effect September 18, ii. Primary care settings like CVIM must screen all people born between 1945 and 1965 for hepatitis C iii. Individuals must be offered the test. We must document offering the test, regardless of if the patient decides to accept testing. iv. If the testing is reactive, we must offer follow up care or refer the patient to appropriate follow up care, including a hepatitis C diagnostic test. B. CVIM Hepatitis C Screening Policy i. All new patients when filling out the Medical Health History form will now be asked two additional questions 1. Would you like to be tested for hepatitis C (suggested if born ) 2. Would you like to discuss issues concerning hepatitis c risk? ii. The HIV Testers will now be involved in asking patients born between if they would like to be tested for hepatitis C
3 iii. The hepatitis C testing can be done for free through our relationships with Chester County Hospital, and only needs to be done one time. iv. If they are found to have active hepatitis c we can refer them to outside gastroenterology for treatment, medications are available through PAP program. Review of Psychiatric Medications at CVIM: Side Effects and Monitoring Parameters Presented by: Stephanie Dangelantonio, Song Oh, Philip Masaitis, PharmD Candidate 2017 I. Selection of treatment consist of many factors (listed below). However, because psychiatric medications have comparable efficacy, both within classes and between classes we base our choice primarily on the safety, tolerability, and side-effects. a. Patient preference b. Prior response c. Family history d. Side-effect profile e. Comorbidities f. Drug interactions g. Half-life h. Cost II. Selective Serotonin Reuptake Inhibitors (SSRI) i. Insomnia, headache, drowsiness, anxiety, nervousness, yawning, decreased libido, nausea, diarrhea, anorexia, dry mouth, weight gain, menstrual changes i. SSRI selectively blocks reabsorption of serotonin into presynaptic neuron, resulting in increased serotonin level at synapse III. Serotonin-Norepinephrine Reuptake Inhibitors (SNRI) i. Hypertension, sexual dysfunction, nausea, vomiting, headache, insomnia i. Inhibition of serotonin and norepinephrine reuptake IV. Tricyclic Antidepressants (TCA) i. Anticholinergic symptoms, drowsiness, weight gain, orthostatic hypotension, conduction abnormalities, sexual dysfunction, dry mouth i. TCA inhibits the reuptake of serotonin and norepinephrine V. Lithium i. Fine hand tremor, initial GI complaints (N/V), pruritic acne, alopecia, chronic folliculitis, polydipsia, polyuria, leukocytosis, edema, excessive weight gain, reversible ECG changes, hypothyroidism, diabetes insipidus, arthritis i. Precise mechanism is unknown. Possible mechanism of action is thought to be alteration of sodium transport in nerve and muscle cells resulting intra-neuronal metabolism of catecholamine c. Toxicity i. Lithium level > 1.5 meq/l (Life-threatening if > 2 meq/l) ii. Acute symptoms: 1. Coarse tremor, nausea, diarrhea, blurred vision, vertigo, confusion
4 VI. iii. Severe neurological complications: 1. Seizures, coma, cardiac dysrhythmia, permanent neurological impairment iv. Treatments: 1. Discontinue lithium 2. Supportive care 3. Consider hemodialysis if level > 4 meq/l Atypical Antipsychotics i. Akathisia, increased triglycerides, weight gain, headache, extrapyramidal symptoms, fatigue, restlessness, tremor, increased appetite i. Atypical antipsychotics are agonists of dopamine and serotonin receptors VII. Conclusion a. Primary care physicians and psychiatrists should work closely to examine patient as a whole and provide optimal and individualized patient care b. Proper baseline parameters allow clinicians to rule out non-psychiatric etiologies for patients symptoms c. Standardizing monitoring parameters for psychiatric medications help minimize adverse events and allow clinicians to make proper adjustments to therapy d. Pregnancy test should be done for all female patients in child-bearing age and clinicians must discuss options for contraceptive options prior to initiating psychiatric medications
5 Atypical Antipsychotics Monitoring Parameters for Psychiatric Medications Parameters Baseline Every visit Every 3 month Annually Waist circumference Fasting blood glucose Thyroid function test Hemoglobin A1c Fasting lipid panel Resolution of symptoms Pregnancy test Evaluate/Discuss SSRIs and SNRIs Parameters Baseline Every visit Every 6 month Annually Thyroid function test CBC Electrolytes Resolution of symptoms Pregnancy test Evaluate/Discuss TCAs Parameters Baseline Every visit Every 6 month Annually Thyroid function test CBC Liver function test Resolution of symptoms Pregnancy test Evaluate/Discuss Dental evaluation ECG* *If cardiac risk factors, over the age of 35, concomitant drug use which prolongs QT interval Lithium Parameters Baseline Every visit Every 6 month Annually Thyroid function test CBC Serum creatinine BUN Resolution of symptoms Pregnancy test Evaluate/Discuss ECG* Lithium level ( meq/l) Check trough level (12 hours after last dose) after 10 days, then Q3-6 months in stable patients *If cardiac risk factors, over the age of 35 Prepared by: Song Oh, Stephanie Dangelantonio, Philip Masaitis, PharmD Candidates 2017
6 List of Available Psychiatric Medications at CVIM Class Selective Serotonin Reuptake Inhibitors (SSRI) Drugs Fluoxetine (Prozac) Citalopram (Celexa) Escitalopram (Lexapro) Paroxetine (Paxil) Sertraline (Zoloft) Fluvoxamine (Luvox CR) Serotonin/Norepinephrine Reuptake Inhibitor (SNRI) Alpha-2 antagonist Tricyclic antidepressant (TCA) Dopamine/Norepinephrine-reuptake inhibitor Duloxetine (Cymbalta) Venlafaxine (Effexor XR) Desvenlafaxine (Pristiq) Mirtazapine (Remeron) Amitriptyline (Elavil) Nortriptyline (Pamelor) Doxepin (Silenor) Bupropion (Wellbutrin, Zyban) Serotonin Reuptake Inhibitor/Antagonist Trazodone (Oleptro) Haloperidol (Haldol) Antipsychotics SSRI/5-HT1A receptor partial agonist SSRI/5-HT1A receptor partial agonist/5-ht3 receptor antagonist Anticholinergic Antimanic agent Antianxiety agent Combination therapy Aripiprazole (Abilify) Brexpiprazole (Rexulti) Lurasidone (Latuda) Risperidone (Risperdal) Quetiapine (Seroquel) Olanzapine (Zyprexa) Vilazodone (Viibryd) Vortioxetine (Trintellix) Benztropine (Cogentin) Lithium (Lithobid) Buspirone (Buspar) Olanzapine/Fluoxetine (Symbyax)
7 Antipsychotic Monitoring Flow Sheet Date Weight Waist Circumference Blood Pressure Heart rate TSH T4 Fasting Blood Glucose Hemoglobin A1c Total cholesterol HDL-C LDL-C Triglycerides Parameters Baseline Every visit Every 3 month Annually Waist circumference Fasting blood glucose Hemoglobin A1c Fasting Lipid Panel Thyroid Function Test Resolution of Symptoms Pregnancy test Discuss/Evaluate
8 Side Effect Profile of Psychiatric Medications Antidepressants Medication Insomnia & Anticholinergic Nausea or Sexual Sedation Hypotension agitation effects GI effects dysfunction Weight gain Selective serotonin reuptake inhibitors (SSRIs) Fluoxetine (Prozac) ++ 0/+ 0/+ 0/ Paroxetine (Paxil) ++ 0/+ 0/ Sertraline (Zoloft) ++ 0/+ 0/+ 0/ Fluvoxamine (Luvox) /+ 0/ Citalopram (Celexa) ++ 0/+ 0/+ 0/ Escitalopram (Lexapro) ++ 0/+ 0/+ 0/ Serotonin and norepinephrine reuptake inhibitors (SNRIs) Venlafaxine (Effexor) ++ 0/+ 0/+ 0/ /+ Desvenlafaxine (Pristiq) ++ 0/+ 0/+ 0/ /+ Duloxetine (Cymbalta) 0/+ + 0/ /+ 0/+ Tricyclic antidepressants (TCAs) Amitriptyline (Elavil) 0/ / Nortriptyline (Pamelor) /+ + + Atypical Antipsychotics Medication Sedation EPS Anticholinergic Orthostasis Weight gain Glucose Lipid QTc dysregulation abnormality prolongation Aripiprazole (Abilify) + +/- +/ /- +/- +/- Brexpiprazole (Rexulti) + + +/ /- +/- + Lurasidone (Latuda) /- +/- + Risperidone (Risperdal) /- Quetiapine (Seroquel) Olanzapine (Zyprexa) Key: 0 = absent, +/- = negligible, + = mild, ++ = moderate, +++ = severe List is not all inclusive References: 1. Mann JJ. The medical management of depression. N Engl J Med Oct 27;353(17): Crismon, M. Lynn, et al. "Chapter 50. Schizophrenia." Pharmacotherapy: A Pathophysiologic Approach, 9e. Eds. Joseph T. DiPiro, et al. New York, NY: McGraw-Hill, 2014.
Review of Psychotrophic Medications. (An approved North Carolina Division of Health Services Regulation Continuing Education Course)
Review of Psychotrophic Medications (An approved North Carolina Division of Health Services Regulation Continuing Education Course) Common Psychiatric Disorders *Schizophrenia *Depression *Bipolar Disorder
More informationBRIEF ANTIDEPRESSANT OVERVIEW. Casey Gallimore, Pharm.D., M.S.
BRIEF ANTIDEPRESSANT OVERVIEW Casey Gallimore, Pharm.D., M.S. Antidepressant Medication Classes First Generation Tricyclic Antidepressants (TCAs) Monoamine Oxidase Inhibitors (MAOIs) Second Generation
More informationAntidepressant Medication Strategies We ve Come a Long Way or Have We? Who Writes Prescriptions for Psychotropic Medications. Biological Psychiatry
Antidepressant Medication Strategies We ve Come a Long Way or Have We? Joe Wegmann, PD, LCSW The PharmaTherapist Joe@ThePharmaTherapist.com 504.587.9798 www.pharmatherapist.com Are you receiving our free
More informationSchedule FDA & literature based indications
Psychotropic Medication List Recommended dosages are intended to serve only as a guide for children. Recommended doses are literature based. Clinicians should consult package insert of medications for
More informationNew Patient Questionnaire
4 Embarcadero Center, Suite 1400, San Francisco, CA 94111 (415) 926-7774 phone; (415) 591-7760 office@sanfranciscopsych.com New Patient Questionnaire Thank you for trusting San Francisco Psychiatry with
More informationTreat mood, cognition, and behavioral disturbances associated with psychological disorders. Most are not used recreationally or abused
Psychiatric Drugs Psychiatric Drugs Treat mood, cognition, and behavioral disturbances associated with psychological disorders Psychotropic in nature Most are not used recreationally or abused Benzodiazepines
More informationPSYCHIATRIC DRUGS. Mr. D.Raju, M.pharm, Lecturer
PSYCHIATRIC DRUGS Mr. D.Raju, M.pharm, Lecturer PSYCHIATRIC DRUGS Treat mood, cognition, and behavioral disturbances associated with psychological disorders Psychotropic in nature Most are not used recreationally
More informationA Brief Overview of Psychiatric Pharmacotherapy. Joel V. Oberstar, M.D. Chief Executive Officer
A Brief Overview of Psychiatric Pharmacotherapy Joel V. Oberstar, M.D. Chief Executive Officer Disclosures Some medications discussed are not approved by the FDA for use in the population discussed/described.
More informationDiagnosis & Management of Major Depression: A Review of What s Old and New. Cerrone Cohen, MD
Diagnosis & Management of Major Depression: A Review of What s Old and New Cerrone Cohen, MD Why You re Treating So Much Mental Health 59% of Psychiatrists Are Over the Age of 55 AAMC 2014 Physician specialty
More informationJudges Reference Table for the March 2016 Psychotropic Medication Utilization Parameters for Foster Children
Judges Reference Table for the Psychotropic Medication Utilization Parameters for Foster Children Stimulants for treatment of ADHD Preschool (Ages 3-5 years) Child (Ages 6-12 years) Adolescent (Ages 13-17
More informationPHYSICIAN REFERENCE ANTIDEPRESSANT DOSING GUIDELINES
PHYSICIAN REFERENCE ANTIDEPRESSANT DOSING GUIDELINES Table of Contents Print TABLE OF CONTENTS Drug Page Number Anafranil... 2 Asendin... 4 Celexa... 4 Cymbalta... 6 Desyrel... 8 Effexor...10 Elavil...14
More informationPsychiatric Medication Guide
Psychiatric Medication Guide F O R : N E O N P R I M A R Y H E A L T H C A R E P R O V I D E R S B Y : M I C H E L L E R O M E R O, D O M A Y, 2 0 1 3 Anti-depressants TCA s & MAOI s (Tricyclic Antidepressants
More informationPresentation is Being Recorded
Integrated Care for Depression & Anxiety Psychotropic Medication Management for Primary Care Providers Los Angeles County Department of Mental Health September 20, 2011 Presentation is Being Recorded Please
More informationChildren s Hospital Of Wisconsin
Children s Hospital Of Wisconsin Co-Management Guidelines To support collaborative care, we have developed guidelines for our community providers to utilize when referring to, and managing patients with,
More information9/20/2011. Integrated Care for Depression & Anxiety: Psychotropic Medication Management for PCPs. Presentation is Being Recorded
Integrated Care for Depression & Anxiety Psychotropic Medication Management for Primary Care Providers Los Angeles County Department of Mental Health September 20, 2011 Presentation is Being Recorded Please
More information2015 Update on Psychotropics
2015 Update on Psychotropics Jeffrey T. Apter, M.D. August 2015 Princeton Medical Institute 256 Bunn Drive, Suite 6, Princeton NJ (609) 921-6050 Learning Objectives Upon completion of this session, participants
More informationPSYCHIATRY INTAKE FORM
Please complete all information on this form. PSYCHIATRY INTAKE FORM Name Date Date of Birth Primary Care Physician Current Therapist/Counselor What are the problem(s) for which you are seeking help? 1.
More informationMood Disorders.
Mood Disorders Shamim Nejad, MD Medical Director, Psycho-Oncology Services Swedish Cancer Institute Swedish Medical Center Seattle, Washington Shamim.Nejad@swedish.org Disclosures Neither I nor my spouse/partner
More informationQuick Guide to Common Antidepressants-Adults
Quick Guide to Common Antidepressants-Adults Medication Therapeutic Range (mg/day) Initial Suggested Serotonin Reuptake Inhibitors (SSRIs) All available as generic FLUOXETINE (Prozac) CITALOPRAM (Celexa
More informationFROM MEDICATION TO MINDFULNESS: NEW INSIGHTS INTO THE WORLD OF ANXIETY
13 th Pearl Leibovitch Clinical Day November 18th, 2014 Mounir H. Samy, MD, FRCP(C) Associate Professor of Psychiatry McGill University (ret.) FROM MEDICATION TO MINDFULNESS: NEW INSIGHTS INTO THE WORLD
More informationPsychiatry in Primary Care: What is the Role of Pharmacist?
Psychiatry in Primary Care: What is the Role of Pharmacist? Benjamin Chavez, PharmD, BCPP, BCACP Clinical Associate Professor Director of Behavioral Health Pharmacy Services January 12, 2019 Disclosure
More informationPsychobiology Handout
Nsg 85A / Psychiatric Page 1 of 7 Psychobiology Handout STRUCTURE AND FUNCTION OF THE BRAIN Psychiatric illness and the treatment of psychiatric illness alter brain functioning. Some examples of this are
More informationHappy Daisy Ltd. New Client intake Form. What are the issues for which you are seeking care?
Happy Daisy Ltd. New Client intake Form Name Date Preferred name Pronouns Referred by Date of birth Age Race What are the issues for which you are seeking care? 1. 2. 3. Please check of any of the symptoms
More informationPsychotropic Medications Archana Jhawar, PharmD, BCPP Clinical Faculty of UIC Pharmacy Practice Clinical Psychiatric Pharmacist Jesse Brown VA
Psychotropic Medications Archana Jhawar, PharmD, BCPP Clinical Faculty of UIC Pharmacy Practice Clinical Psychiatric Pharmacist Jesse Brown VA Goals of Medications Use least number at lowest dose to get
More informationMental Illness. Doreen L. Rasp, APN, FNP, PMHNP Advanced Behavioral Counseling
Mental Illness Doreen L. Rasp, APN, FNP, PMHNP Advanced Behavioral Counseling Moodiness Changing Bodies Narcissism Self-Esteem Ignorant Naïve Insecure Self-Centered Independent Adolescence Disorders Affecting
More informationMedications and Children Disorders
Mental Health Comprehensive Services Providing Family Stability and Developing Life Coping Skills Medications and Children Disorders Psychiatric medications can be an effective part of the treatment for
More informationCOMMONLY PRESCRIBED PSYCHOTROPIC MEDICATIONS NAME Generic (Trade) DOSAGE KEY CLINICAL INFORMATION Antidepressant Medications*
COMMONLY PRESCRIBED PSYCHOTROPIC MEDICATIONS NAME Generic (Trade) DOSAGE KEY CLINICAL INFORMATION Antidepressant Medications* Bupropion (Wellbutrin) Start: IR-100 mg bid X 4d then to 100 mg tid; SR-150
More informationCommon Antidepressant Medications for Adults
(and Citalopram (Celexa) Escitalopram (Lexapro) Fluoxetine (Prozac) Fluoxetine Weekly (Prozac Weekly) 20 in AM w/ food (10 mg in elderly or those w/ panic disorder) 20 40 40 (If age >60yo, max 20) 10 10
More informationPsychiatric Illness. In the medical arena psychiatry is a fairly recent field A challenging field Numerous diagnosis
Psychiatric Illness In the medical arena psychiatry is a fairly recent field A challenging field Numerous diagnosis 12,000,000 children infants through 18 y/o nation wide 5,000,000 suffer severely Serious
More informationSteps for Initiating Electroconvulsive Therapy Treatment
Steps for Initiating Electroconvulsive Therapy Treatment PSYCHIATRISTS CAN REFER PATIENTS FOR ECT TREATMENT AT EL CAMINO HOSPITAL BY CALLING THE ECT NURSE COORDINATOR AT 650-962-5795. Once the referral
More informationANTI-DEPRESSANT MEDICATIONS
ANTI-DEPRESSANT MEDICATIONS This information is not intended to be a substitute for medical advice. It s purpose is solely informative. If your client or yourself are taking antidepressants, do not change
More informationMedications for Anxiety & Behavior in Williams Syndrome. Disclosure of Potential Conflicts. None 9/22/2016. Evaluation
Medications for Anxiety & Behavior in Williams Syndrome Christopher J. McDougle, M.D. Director, Lurie Center for Autism Professor of Psychiatry and Pediatrics Massachusetts General Hospital and MassGeneral
More informationGuide to Psychiatric Medications for Children and Adolescents
Guide to Psychiatric Medications for Children and Adolescents by Glenn S. Hirsch, M.D. The following guide includes most of the medications used to treat child and adolescent mental disorders. It lists
More informationDementia Medications Acetylcholinesterase Inhibitors (AChEIs) and Glutamate (NMDA) Receptor Antagonist
Dementia Medications Acetylcholinesterase Inhibitors (AChEIs) and Glutamate (NMDA) Receptor Antagonist Medication Dosage Indication for Use Aricept (donepezil) Exelon (rivastigmine) 5mg 23mg* ODT 5mg Solution
More informationAntidepressant Selection in Primary Care
Antidepressant Selection in Primary Care Rebecca D. Lewis, DO OOA Summer CME Oklahoma City, OK 6 August 2017 Objectives Understand the epidemiology of depression. Recognize factors to help choose antidepressants.
More informationUsing Drugs to Improve the Behavior of People with Autism: A Skeptical Appraisal. Alan Poling, Ph.D., BCBA-D Western Michigan University
Using Drugs to Improve the Behavior of People with Autism: A Skeptical Appraisal Alan Poling, Ph.D., BCBA-D Western Michigan University In a 2010 study of 60,641 children Mandell et al. found that: 56%
More informationPsychiatry curbside: Answers to a primary care doctor s top mental health questions
Psychiatry curbside: Answers to a primary care doctor s top mental health questions April 27, 2018 Laurel Ralston, DO Psychiatrist, Taussig Cancer Institute Objectives Review current diagnostic and prescribing
More informationAntidepressants. Dr Malek Zihlif
Antidepressants The optimal use of antidepressant required a clear understanding of their mechanism of action, pharmacokinetics, potential drug interaction and the deferential diagnosis of psychiatric
More informationPrimary Care Management of Depression. John Briles, MD, Medical Director October 11, 2017
John Briles, MD, Medical Director October 11, 2017 Molina Healthcare of Michigan uses a HEDIS measure for Antidepressant Medication Management (AMM) to measure how well treating providers (PCPs) appropriately
More informationIMPORTANT NOTICE. Changes to dispensing of some Behavioral Health Medications for DC Healthcare Alliance members
IMPORTANT NOTICE Changes to dispensing of some Behavioral Health Medications for DC Healthcare Alliance members These changes apply only to members covered under the DC Healthcare Alliance program Alliance
More informationAdult Depression - Clinical Practice Guideline
1 Adult Depression - Clinical Practice Guideline 05/2018 Diagnosis and Screening Diagnostic criteria o Please refer to Attachment A Screening o The United States Preventative Services Task Force (USPSTF)
More information8/15/17. Managing Psychiatric Conditions in Primary Care Beyond the Basics. Speaker s Biography. Situation
Managing Psychiatric Conditions in Primary Care Beyond the Basics Source: US National Library of Medicine, Images from the History of Medicine Luis Berrios, DNP, MHA, ANP, PMHNP Internal Medicine & Primary
More informationDepression & Anxiety in Adolescents
Depression & Anxiety in Adolescents Objectives 1) Review diagnosis of anxiety and depression in adolescents 2) Provide overview of evidence-based treatment options 3) Increase provider comfort level with
More informationDepression. University of Illinois at Chicago College of Nursing
Depression University of Illinois at Chicago College of Nursing 1 Learning Objectives Upon completion of this session, participants will be better able to: 1. Recognize depression, its symptoms and behaviors
More informationTreating Depression in Adults
Treating Depression in Adults By Deborah Christensen, Ph.D., M.S.C.P. Depressive Disorders represent a broad and heterogeneous group of commonly diagnosed psychological disorders. The DSM adequately describes
More informationManagement of SSRI Induced Sexual Dysfunction. Serotonin Reuptake Inhibitors*
Management of SSRI Induced Sexual Dysfunction John J. Miller, M.D. Medical Director, Center for Health and WellBeing Exeter, NH Serotonin Reuptake Inhibitors* fluoxetine clomipramine sertraline paroxetine
More informationAnti-Depressant Medications
Anti-Depressant Medications A Introduction: This topic may be a little bit underestimated here in Jordan, while in western countries it has more significance. The function of anti-depressants is to change
More information90 dosage units per 90 days OR. Extended-release Formulations Ultram ER 90 dosage units per 90 days OR
Pre - PA Allowance 12 years of age or older Quantity Immediate-release Formulation Ultracet 720 dosage units per 90 days OR Ultram 720 dosage units per 90 days Extended-release Formulations Ultram ER 90
More informationRichard Heidenfelder M.D. Child, Adolescent and Adult Psychiatry 447 9th Ave San Diego, CA
*We are not accepting any New Patients who are currently taking any controlled pain medications *We are *Note: not completion accepting of the any following New Patients paperwork who and Initial are Screening
More informationMental Health Intake Form
Current Symptoms Checklist: (check once for any symptoms present, twice for major symptoms) ( ) ( ) Depressed mood ( ) ( ) Racing thoughts ( ) ( ) Excessive worry ( ) ( ) Unable to enjoy activities ( )
More informationDr.Rahiminejad Roozbeh Hospital TUMS
Dr.Rahiminejad Roozbeh Hospital TUMS Psychiatric disorders, particularly depression, anxiety and eating disorders, are prevalent in diabetes. Mental illness increases risk of diabetes and diabetic complications.
More informationIt is the policy of health plans affiliated with Centene Corporation that Seroquel XR is medically necessary when the following criteria are met:
Clinical Policy: (Seroquel XR) Reference Number: CP.PMN.64 Effective Date: 12.01.14 Last Review Date: 02.18 Line of Business: Commercial, Health Insurance Marketplace, Medicaid Revision Log See Important
More informationTREATMENT OF DEPRESSION IN LATE LIFE. Robert Kohn, MD
TREATMENT OF DEPRESSION IN LATE LIFE Robert Kohn, MD WHY TREAT ELDERLY PERSONS Major depression is not a normal part of aging The rates are lower than younger cohorts The prevalence rates are still high
More informationMORPHINE IR DRUG CLASS Morphine IR, Dilaudid IR (hydromorphone), Opana IR (oxymorphone)
Pre - PA Allowance Tablets & Suppositories Morphine sulfate tablets Morphine sulfate suppositories Oxymorphone tablets Hydromorphone tablets Hydromorphone suppositories 360 tablets per 90 days OR 360 suppositories
More informationDuragesic Patch (fentanyl patch) Prior authorization is not required if prescribed by an oncologist
Pre - PA Allowance Quantity 30 patches every 90 days Prior-Approval Requirements Prior authorization is not required if prescribed by an oncologist Age 2 years of age or older Diagnosis Patient must have
More informationOverview and Update on Current Psychopharmacological Medications, Including New Medications in Clinical Trials
SPEAKER NOTES Overview and Update on Current Psychopharmacological Medications, Including New Medications in Clinical Trials Summarized by Thomas T. Thomas New psychotropic medications are coming on the
More informationRealities of Depression in Primary Care Setting
Realities of Depression in Primary Care Setting Jaroslava Salman, MD Department of Supportive Care Medicine Division of Psychiatry Click to edit Master Presentation Date August 4 th 2018 Disclosure I have
More informationUSF Health Psychiatry Clinic. New Patient Questionnaire Adult
USF Health Psychiatry Clinic New Patient Questionnaire Adult Please mail or fax the completed forms to the address/fax number on the bottom of this page. Completed forms must be received five (5) days
More informationRiding the Waves: Tools for the Management of Bipolar Disorder
Riding the Waves: Tools for the Management of Bipolar Disorder Jacintha S. Cauffield, Pharm.D., BCPS, CDE Associate Professor of Pharmacy Practice Palm Beach Atlantic University Lloyd L. Gregory School
More informationHYSINGLA ER (hydrocodone bitartrate) Prior authorization is not required if prescribed by an oncologist.
Pre - PA Allowance None Prior authorization is not required if prescribed by an oncologist. Prior-Approval Requirements Age 18 years of age or older Diagnosis Patient must have the following: 1. Pain,
More informationAffective or Mood Disorders. Dr. Alia Shatanawi March 12, 2018
Affective or Mood Disorders Dr. Alia Shatanawi March 12, 2018 Affective or Mood Disorders Reactive Depression. Secondary: Medical Neurological Drugs Major (Endogenous) Depression = Unipolar: Depressed
More informationPre - PA Allowance. Prior-Approval Requirements LEVORPHANOL TARTRATE. None
Pre - PA Allowance None Prior-Approval Requirements Prior authorization is not required if prescribed by an oncologist and/or the member has paid pharmacy claims for an oncology medication(s) in the past
More informationFamily Medicine Forum November 10, 2017 Montreal., Quebec. Jon Davine, CCFP, FRCP(C) Associate Professor, McMaster University
APPROACH TO DEPRESSION IN PRIMARY CARE Family Medicine Forum November 10, 2017 Montreal., Quebec. Jon Davine, CCFP, FRCP(C) Associate Professor, McMaster University DISCLOSURE Speaker/Presenter Disclosure
More informationStudy Guidelines for Quiz #1
Annex to Section J Page 1 Study Guidelines for Quiz #1 Theory and Principles of Psychopharmacology, Classifications and Neurotransmitters, Anxiolytics/Antianxiety/Minor Tranquilizers, Stimulants, Nursing
More information4/2/13 COMMON CLASSES OF MEDICATIONS. Child & Adolescent Behavioral Medicine & Medication Therapies. Behavioral Medicine & Medication Therapies
Child & Adolescent Behavioral Medicine & Medication Therapies Brian J Cowles, PharmD Associate Professor of Pharmacy Practice Albany College of Pharmacy & Health Sciences; Vermont Campus Behavioral Medicine
More informationTOP APS DRUGS TRAZODONE BRAND NAMES: OLEPTRO, DESYREL (DIVIDOSE) & TRIALODINE
trazodone TOP APS DRUGS TRAZODONE BRAND NAMES: OLEPTRO, DESYREL (DIVIDOSE) & TRIALODINE Pharmacodynamics study of what a drug does to the body Studies show that trazodone selectively inhibits neuronal
More informationOXYCODONE IR (oxycodone)
RATIONALE FOR INCLUSION IN PA PROGRAM Background Oxycodone hydrochloride, a pure opioid agonist, is used in the treatment of moderate to severe pain (1-2). The precise mechanism of action is unknown; however,
More informationThe Use of Antidepressants in the Treatment of Irritable Bowel Syndrome and Other Functional GI Disorders What are functional GI disorders?
The Use of Antidepressants in the Treatment of Irritable Bowel Syndrome and Other Functional GI Disorders Christine B. Dalton, PA-C Douglas A. Drossman, MD and Kellie Bunn, PA-C What are functional GI
More informationAntidepressant Selection in Primary Care
Antidepressant Selection in Primary Care R E B E C C A D. L E W I S, D O O O A S U M M E R C M E B R A N S O N, M O 1 5 A U G U S T 2 0 1 5 Objectives Understand the epidemiology of depression. Recognize
More informationMental Health Intake Form
38600 Van Dyke Ave., Suite 200 Sterling Heights, MI 48313 Phone: (586) 933-5395 Fax: (586) 935-0159 Mental Health Intake Form Please complete all information on this form and bring it to the first visit.
More informationIntroduction to Drug Treatment
Introduction to Drug Treatment LPT Gondar Mental Health Group www.le.ac.uk Introduction to Psychiatric Drugs Drugs and Neurotransmitters 5 Classes of Psychotropic medications Mechanism of action Clinical
More informationDaniel Suzuki, MD Adjunct Clinical Associate Professor of Psychiatry, USC Keck School of Medicine Clinical Adjunct Professor/Faculty, Graduate School
Daniel Suzuki, MD Adjunct Clinical Associate Professor of Psychiatry, USC Keck School of Medicine Clinical Adjunct Professor/Faculty, Graduate School of Psychology, Fuller Theological Seminary Medical
More informationDrugs for Emotional and Mood Disorders Chapter 16
Drugs for Emotional and Mood Disorders Chapter 16 NCLEX-RN Review Question 1 Choices Please note Question #1 at the end of Ch 16 pg 202 & Key pg 805 answer is #4 1. Psychomotor symptoms 2. Tachycardia,
More informationBELBUCA (buprenorphine buccal film)
RATIONALE FOR INCLUSION IN PA PROGRAM Background Belbuca is indicated for the management of chronic pain severe enough to require daily, aroundthe-clock, long-acting opioid treatment for which alternative
More informationAntidepressants: Prof. Riyadh Al_Azzawi F.R.C.Psych
Antidepressants: Prof. Riyadh Al_Azzawi F.R.C.Psych A. Heterocyclic antidepressants: (tricyclic and tetracyclic ), e.g.amitryptaline,imipramine. B. Monoamine oxidase inhibitors(m.a.o.i), e.g.phenelzine.
More informationTRANSCRANIAL MAGNETIC STIMULATION & BRAIN MUSIC THERAPY
TMS - DEPRESSION HISTORY Date: Patient Name: DOB: How did you hear about TMS? What do you know about TMS? Referring Physician? Name of Practice: Name of Inpatient Treatment for Depression: Name of Inpatient
More informationPharmacists in Medication Adherence in Psychiatric Patients
Pharmacists in Medication Adherence in Psychiatric Patients Mamta Parikh, PharmD, BCPS, BCPP Assistant Professor, Clinical and Administrative Sciences Notre Dame of Maryland University School of Pharmacy
More informationDepression: A Darker Shade of Blue. CareOregon Pharmacy
Depression: A Darker Shade of Blue CareOregon Pharmacy Today s Agenda Welcome and Introduction 8:00 Clinical & In Real Life Aspects 8:05 Break 9:15 Medication Review 9:30 Questions 10:30 Closing 10:55
More informationTreatment of Major Depressive Disorder
Treatment of Major Depressive Disorder Sarah Mullowney, MD PGY3 Psychiatry Resident, University of Utah Paula Gibbs, MD Medical Director of 5 West at UUMC Clerkship Director MS III Psychiatric Rotation
More informationWeighty Issues with Psychotropic Use in Adolescents and Young Adults
Weighty Issues with Psychotropic Use in Adolescents and Young Adults Sheila Botts, PharmD, BCPP, FCCP Chief, Clinical Pharmacy Research & Academic Affairs Kristen N. Gardner, PharmD Clinical Pharmacy Specialist
More informationAppendix: Psychotropic Medication Reference Tables
Appendix: Psychotropic Medication Reference Tables How to Use these Tables These reference tables are designed to provide clinic staff with specific medication related criteria for the Polypharmacy, Cardiometabolic
More informationDepression. There are several forms of depression (depressive disorders). Major depressive disorder and dysthymic disorder are the most common.
Depression Depression is a state of low mood and aversion to activity that can affect a person's thoughts, behavior, feelings and sense of well-being. People with depressed mood can feel sad, anxious,
More informationPsychiatric Medications. Positive and negative effects in the classroom
Psychiatric Medications Positive and negative effects in the classroom Teaching the Medicated Child Beverly Bryant, M.D. Hattiesburg Clinic 9/17/14 Introduction According to the National Survey of Children
More information3. Atypical antidepressants
3. Atypical antidepressants Bupropion, mirtazapine, nefazodone & trazodone. Mixed group that act at several different sites. Bupropion Acts as a weak dopamine & NE reuptake inhibitor. Has short half-life.
More informationMedications, By Class, in TBI
Medications, By Class, in TBI Generic/Brand Name Drawback Advantage Mood Stabilizers (anti-seizure medications) Carbamazepine (Carbatrol ) (Equetro ) (Tegretol ) Gabapentin (Neurontin ) Lamotrigine (Lamictal
More informationAdult Initial Assessment / Patient Questionnaire Page 1
Page 1 Patient Name: Date: Age: Date of Birth: / / Please read the following questions and answer to the best of your ability by placing a checkmark in the appropriate boxes or filling in the blank as
More informationBefore you try another medication, try asking your DNA
Before you try another medication, try asking your DNA It s not you, it s your genetics If you re having trouble finding a medication that works for you, don t give up hope. Here s the thing we all respond
More informationXartemis XR (oxycodone / acetaminophen extended release)
RATIONALE FOR INCLUSION IN PA PROGRAM Background Xartemis XR is a combination of oxycodone and acetaminophen in a dosage formulation to deliver both immediate pain relief, in less than an hour, and extended-release
More informationAnti- Depressants, Mood Stabilizers: What Works Best For Bipolar Disorder? Date: March 30, 2007 Source: NIH/National Institute of.
30-3-2007 Anti- Depressants, Mood Stabilizers: What Works Best For Bipolar Disorder? Date: March 30, 2007 Source: NIH/National Institute of. 30-3-2018 C. Psychiatric drugs: controlled trial demonstrated
More informationPsychopharmacological Management of Depressive and Anxiety Disorders
Psychopharmacological Management of Depressive and Anxiety Disorders Waseem Ahmed, M.D Medical Director: Population Health and Dallas County Correctional System Email: waseem.ahmed@phhs.org Tel: 214-653-2927
More informationAntidepressants Choosing the Right One
Antidepressants Choosing the Right One Dr Lim Boon Leng Consultant Psychiatrist Dr BL Lim Centre For Psychological Wellness #09-09, Gleneagles Medical Centre, 6 Napier Rd, S258499 www.psywellness.com.sg
More informationAntidepressant Pharmacology An Overview
Figure 1. Antidepressant Pharmacology An Overview Source: NEJM 2005;353:1819-34 Figure 2. 1 Figure 3: Antidepressant Pharmacology pictures: Weak inhibition Bupropion NOTE: CYP enzymes noted are those inhibited
More informationRATIONALE FOR INCLUSION IN PA PROGRAM
RATIONALE FOR INCLUSION IN PA PROGRAM Background hydromorphone (Exalgo, Dilaudid) and oxymorphone (Opana and Opana ER) are Schedule II narcotics prescribed to treat moderate to severe pain. Morphine produces
More informationPrepared by: Elizabeth Vicens-Fernandez, LMHC, Ph.D.
Prepared by: Elizabeth Vicens-Fernandez, LMHC, Ph.D. Sources: National Institute of Mental Health (NIMH), the National Alliance on Mental Illness (NAMI), and from the American Psychological Association
More informationThe clinical response to the same dose
Making sense of CYP2D6 and CYP1A2 genotype vs phenotype O. Greg Deardorff, PharmD, BCPP, Victoria Jenne, PharmD, MPH, BCPS, and Lauren Leonard, PharmD The clinical response to the same dose of a drug may
More informationPsychotropic Medication Use in Dementia
Psychotropic Medication Use in Dementia Marie A DeWitt, MD Diplomate of the American Board of Psychiatry and Neurology, Specialization in Psychiatry & Subspecialization in Geriatric Psychiatry Staff Physician,
More informationThis initial discovery led to the creation of two classes of first generation antidepressants:
Antidepressants - TCAs, MAOIs, SSRIs & SNRIs First generation antidepressants TCAs and MAOIs The discovery of antidepressants could be described as a lucky accident. During the 1950s, while carrying out
More informationDepression in Pregnancy
TREATING THE MOTHER PROTECTING THE UNBORN A MOTHERISK Educational Program The content of this program reflects the expression of a consensus on emerging clinical and scientific advances as of the date
More information